Anthony L. Cunningham

25.6k total citations · 3 hit papers
382 papers, 18.1k citations indexed

About

Anthony L. Cunningham is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Anthony L. Cunningham has authored 382 papers receiving a total of 18.1k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Epidemiology, 147 papers in Immunology and 133 papers in Virology. Recurrent topics in Anthony L. Cunningham's work include Herpesvirus Infections and Treatments (160 papers), HIV Research and Treatment (108 papers) and Cytomegalovirus and herpesvirus research (60 papers). Anthony L. Cunningham is often cited by papers focused on Herpesvirus Infections and Treatments (160 papers), HIV Research and Treatment (108 papers) and Cytomegalovirus and herpesvirus research (60 papers). Anthony L. Cunningham collaborates with scholars based in Australia, United States and Brazil. Anthony L. Cunningham's co-authors include Russell J. Diefenbach, Monica Miranda‐Saksena, Stuart Turville, Zorka Mikloška, Andrew N. Harman, Hassan M. Naif, Dominic E. Dwyer, Ross Boadle, Allison Abendroth and Barry Slobedman and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Anthony L. Cunningham

376 papers receiving 17.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients

1995 982 citations Suzanne M. Crowe, Anthony L. Cunningham et al. profile →
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

2015 906 citations Anthony L. Cunningham et al. profile →
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

2002 583 citations Lawrence R. Stanberry, Spotswood L. Spruance et al. profile →

Peers

Countries citing papers authored by Anthony L. Cunningham

Since Specialization

Citations

This map shows the geographic impact of Anthony L. Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony L. Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony L. Cunningham more than expected).

Fields of papers citing papers by Anthony L. Cunningham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony L. Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony L. Cunningham. The network helps show where Anthony L. Cunningham may publish in the future.

Co-authorship network of co-authors of Anthony L. Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony L. Cunningham. A scholar is included among the top collaborators of Anthony L. Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony L. Cunningham. Anthony L. Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent 2024 ·Journal of Clinical Investigation ·(unknown), Kirstie M. Bertram, (unknown), (unknown), Heeva Baharlou, (unknown), (unknown), Elisabeth Elder, James French, (unknown), Stéphane Temmerman, Arnaud M. Didierlaurent, Margherita Coccia, Kerrie J. Sandgren, Anthony L. Cunningham	4
2	Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention 2024 ·Infectious Diseases and Therapy ·(unknown), Anthony L. Cunningham, Francisco Arnalich‐Montiel, Raunak Parikh	7
3	Advances in understanding the mechanism of action of adult vaccines 2023 ·Journal of Clinical Investigation ·Anthony L. Cunningham, Kerrie J. Sandgren, Naomi R. Truong	4
4	Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion 2022 ·Blood ·Yandong Shen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ian Kerridge, (unknown), Anouschka Akerman, Anupriya Aggarwal, Vanessa Milogiannakis, (unknown), (unknown), Kerrie J. Sandgren, Stuart Turville, Anthony L. Cunningham, Stephen P. Mulligan	17
5	COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity 2021 ·British Journal of Haematology ·Yandong Shen, (unknown), (unknown), (unknown), (unknown), Asha Soosapilla, (unknown), Catherine Tang, Ian Kerridge, (unknown), (unknown), Vanessa Milogiannakis, Anouschka Akerman, (unknown), Kerrie J. Sandgren, Anthony L. Cunningham, Stuart Turville, Stephen P. Mulligan	30
6	Herpes Simplex Virus type 1 infects Langerhans cells and the novel epidermal dendritic cell, Epi-cDC2s, via different entry pathways 2021 ·PLoS Pathogens ·Kirstie M. Bertram, Naomi R. Truong, (unknown), Min Kim, Kerrie J. Sandgren, (unknown), (unknown), (unknown), (unknown), Monica Miranda‐Saksena, Jake W. Rhodes, Ellis Patrick, Ralph C. Cohen, (unknown), Steven Merten, Andrew N. Harman, Anthony L. Cunningham	19
7	Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotype 2021 ·PLoS Pathogens ·Orion Tong, Gabriel Duette, (unknown), Caroline Royle, (unknown), B. H. Johnson, (unknown), Suat Dervish, (unknown), Heeva Baharlou, Ellis Patrick, Grahame Ctercteko, Sarah Palmer, Eunok Lee, Eric Hunter, Andrew N. Harman, Anthony L. Cunningham, Najla Nasr	8
8	Antimicrobial Peptides of Marine Crustaceans: The Potential and Challenges of Developing Therapeutic Agents 2018 ·Current Medicinal Chemistry ·(unknown), Monica Miranda‐Saksena, Anthony L. Cunningham, Fariba Dehghani	26
9	Analysis of T Cell Responses during Active Varicella-Zoster Virus Reactivation in Human Ganglia 2013 ·Journal of Virology ·Megan Steain, (unknown), Michael Rodriguez, Anthony L. Cunningham, Barry Slobedman, Allison Abendroth	97
10	Biology of Mucosally Transmitted Sexual Infection—Translating the Basic Science into Novel HIV Intervention: A Workshop Summary 2012 ·AIDS Research and Human Retroviruses ·Damian F. J. Purcell, Anthony L. Cunningham, Stuart Turville, Gilda Tachedjian, Alan Landay	4
11	Characterization of the Host Immune Response in Human Ganglia after Herpes Zoster 2010 ·Journal of Virology ·Kavitha Gowrishankar, Megan Steain, Anthony L. Cunningham, Michael Rodriguez, Peter Blumbergs, Barry Slobedman, Allison Abendroth	60
12	Neurotropic HIV-1 viruses induce the Kynurenine Pathway (KP) more effectively compared to non-neurotropic viruses in monocyte derived dendritic cells (MDDCs) 2010 ·Journal of NeuroVirology ·(unknown), John Wilkinson, Nabila Seddiki, John Zaunders, Anthony L. Cunningham, Bruce J. Brew	1
13	Viral transport: a protein perspective 2008 ·Russell J. Diefenbach, Anthony L. Cunningham	1
14	An update on short-course intermittent and prevention therapies for herpes labialis. 2007 ·PubMed ·(unknown), Lawrence Corey, Anthony L. Cunningham, (unknown), Lawrence R. Stanberry, Richard J. Whitley, Spotswood L. Spruance	14
15	HIV Induces Maturation of Monocyte-Derived Dendritic Cells and Langerhans Cells 2006 ·The Journal of Immunology ·Andrew N. Harman, John Wilkinson, Christopher R. Bye, Lidija Bosnjak, Josh Lewis Stern, (unknown), Joey Lai, Anthony L. Cunningham	81
16	Retraction Notice:Pathogenesis of Macrophage Tropic HIV-1 2005 ·Current HIV Research ·Paul R. Gorry, Melissa J. Churchill, Suzanne M. Crowe, Anthony L. Cunningham, Dana Gabuzda	80
17	HIV gp120 receptors on human dendritic cells 2001 ·Blood ·Stuart Turville, (unknown), (unknown), Garry W. Lynch, Hassan M. Naif, Georgina J. Clark, Derek N.J. Hart, Anthony L. Cunningham	172
18	Sequence Note : Length Polymorphism of the Viral Protein R of Human Immunodeficiency Virus Type 1 Strains 1996 ·AIDS Research and Human Retroviruses ·(unknown), Bin Wang, Dominic E. Dwyer, Shi-Hua Xiang, Anthony L. Cunningham, (unknown)	4
19	Herpes Simplex Virus Type 2 Antibody in Patients Attending Antenatal or STD Clinics 1994 ·Obstetrical & Gynecological Survey ·Anthony L. Cunningham, Francis K. Lee, David Ho, Peter R. Field, Carmella Law, (unknown), Ian McCrossin, Eva Sjögren‐Jansson, Stig Jeansson, André J. Nahmias	9
20	Role of Macrophage D-Region Antigens and T-Lymphocyte Differentiation Antigens in Induction of Gamma Interferon 1985 ·Journal of Interferon Research ·Anthony L. Cunningham, Teresa Y. Basham, Michael F. Para, Thomas C. Merigan	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact